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In a now classic paper published a half century ago, Tennant
and Wiggers (l) described the effects of brief periods of
myocardial ischemia on cardiac performance in open chest
dogs. They showed that within seconds of coronary artery
occlusion the normal state of active systolic shorteningchanges
to one of passive systolic lengthening, and that after brief
periods of myocardial ischemia, restoration of coronary blood
flow could lead to rapid and complete recovery of normal
contraction. Several years later, Blumgart and collaborators
(2) demonstrated that when reflow occurred more than 20
minutes after coronary occlusion, some degree of myo-
cardial necrosis invariably resulted.
For many years after these seminal observations it was
generally held that when the myocardial oxygen supply/
demand relation becomes imbalanced, regardless of whether
the imbalance is caused by reduced oxygen supply, aug-
mented myocardial oxygen demand or a combination of the
two, the well known biochemical, electrocardiographic, me-
chanical and, in patients, clinical manifestations of acute
ischemia become manifest. It was also believed that 1) when
myocardial oxygen balance is restored before the devel-
opment of irreversible injury, these changes reverse rapidly,
but 2) when the duration of ischemia is prolonged beyond
a critical point, irreversible myocardial damage occurs and
mechanical function cannot be restored. During the last
decade, two related pathophysiologic conditions have been
identified that challenge these concepts. In these two con-
ditions, termed myocardial stunning and myocardial hiber-
nation, major discrepancies occur between myocardial func-
tion and other manifestations of ischemia.
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Myocardial Stunning
It has been observed that periods of severe ischemia that
are too brief to cause myocardial necrosis may nonetheless
be associated with ultrastructural and biochemical changes
and, most importantly, with contractile dysfunction that per-
sists for prolonged periods-hours, days or even weeks-
after restoration of reperfusion. This condition, that is, pro-
longed postischemic ventricular dysfunction without myo-
cardial necrosis, has been referred to as stunning of the
myocardium (3). Initially, myocardial stunning was de-
scribed in experimental animals in which myocardium was
perfused by a coronary artery that was temporarily occluded.
A clinical analogue of this situation is represented by the
patient with severe coronary artery spasm, lasting for 10 to
15 minutes, that is relieved before the development of myo-
cardial necrosis. Stunning also occurs as a consequence of
longer periods of coronary occlusion, in which the most
intensely ischemic tissue, generally the subendocardium,
undergoes irreversible damage. However, large quantities
of myocardium that are adjacent, usually epicardial but
sometimes also lateral, to the necrotic area, but that are not
as severely ischemic, may survive after reflow occurs (4).
This situation is observed clinically when reperfusion is
induced after coronary occlusion and salvages some of the
jeopardized tissue. The return of contractile function in the
salvaged tissue is not immediate, but may require many
days. Myocardial stunning may also occur with ischemia i~
the absence of total coronary occlusion. Thus, Matsuzaki
et al. (5) reported that ischemia maintained for several hours
by subtotal coronary occlusion can also cause left ventricular
dysfunction that persists for days after release of the occlu-
sion and restoration of myocardial blood flow. Stunning has
also been demonstrated in conscious dogs with subtotal
coronary obstruction in which ischemia was induced by
muscular exercise (6).
Mechanism. The function of stunned myocardium can
be improved by the administration of positive inotropic agents
(7). It is characteristic of myocardial stunning that the du-
ration of myocardial dysfunction exceeds, by an order of
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magnitude or more, the duration of the ischemic insult.
However, by definition recovery occurs, albeit hours or days
after the relief of ischemia. The fundamental mechanism
responsible for myocardial stunning has not been defini-
tively elucidated; it may be related to the prolonged reduc-
tion of myocardial high energy phosphate stores which oc-
curs in tissue subjected to prolonged or severe ischemia, or
both (4,8,9).
Hibernating Myocardium
Myocardial stunning that follows a discrete episode of
severe ischemia should be distinguished from the persistent
left ventricular dysfunction that may be the principal clinical
manifestation of chronic myocardial ischemia. When myo-
cardial perfusion is chronically reduced, but is still sufficient
to maintain the viability of the tissue, myocardial function
may remain impaired permanently or for as long as myo-
cardial perfusion is inadequate. Rahimtoola (10) aptly re-
ferred to the myocardium in this condition as hibernating.
It is possible that the impairment of contractile function that
characterizes both stunned and hibernating myocardium serves
as a protective mechanism in that it reduces the oxygen
demands of the hypoperfused myocardium and thereby lim-
its ischemia and necrosis. While these two forms of left
ventricular dysfunction have much in common, it is im-
portant to distinguish between them. Stunned myocardium
results from a discrete episode of ischemia that lasts for
minutes or hours and exhibits impaired contractile perform-
ance persisting for hours or days after its relief. In contrast,
hibernating myocardium results from months or years of
ischemia and ventricular dysfunction persists until blood
flow is restored.
Clinical features. The key feature of myocardial hiber-
nation-prolonged, yet ultimately reversible left ventricular
dysfunction-may occur with or without angina pectoris
or electrocardiographic changes characteristic of myocardial
ischemia. In patients without angina, elevation of left ven-
tricular filling pressure and dyspnea secondary to ventricular
systolic or diastolic dysfunction, or both, may be the pre-
dominant clinical feature of myocardial ischemia (11). It
should not be surprising that left ventricular dysfunction
may occur as a consequence of ischemia, but be unaccom-
panied by angina pectoris or electrocardiographic changes,
because myocardial dysfunction appears to be more sensi-
tive than angina or abnormalities of the surface electrocar-
diogram as an indicator of ischemia. Thus, coronary artery
occlusion carried out during coronary angioplasty causes
abnormalities of myocardial wall motion, which occur be-
fore electrocardiographic changes, which in tum precede
the development of ischemic chest pain (12). Also, the
recent attention to asymptomatic ischemia has demonstrated
that myocardial ischemia is frequently unaccompanied by
angina (13).
Reversible Ventricular Dysfunction
It is important to appreciate the concept of myocardial
hibernation because the symptoms resulting from chronic
left ventricular dysfunction may be inappropriately ascribed
to myocardial necrosis and scarring when they may, in fact,
be reversed when the chronic ischemia is relieved by coro-
nary revascularization (14-16). In the first few years after
the development of coronary artery bypass surgery, the pres-
ence of severe left ventricular dysfunction in the rest state
was considered to be a relative contraindication to revas-
cularization because it was thought to be caused by irre-
versibly damaged myocardium that had been replaced by
scar tissue. However, it is now clear that chronic left ven-
tricular dysfunction is no contraindication to coronary re-
vascularization and that the function of hibernating myo-
cardium may improve after successful revascularization.
Therefore, it is an important challenge to the clinician to
identify among patients with coronary artery disease and
left ventricular dysfunction those with hibernating myocar-
dium whose myocardial dysfunction is potentially reversible
and whose myocardial function will improve after revas-
cularization.· Such improvement in function may occur in
patients with chronic left ventricular dysfunction and angina
as well as in those whose only clinical manifestation of
coronary artery disease is chronic left ventricular failure.
Improved left ventricular function after revasculari-
zation. Intraoperative echocardiography has demonstrated
that improvement in left ventricular function may occur
acutely after coronary revascularization, the most striking
changes occurring in those patients with the poorest baseline
function (17). Successful revascularization that improves
myocardial perfusion at rest (16) and during exercise can
improve left ventricular function. It was demonstrated in
the Coronary Artery Surgery Study (CASS) that the im-
provement in survival achieved by surgical revascularization
occurs primarily in patients with impaired left ventricular
function (18) and that the most salutary changes are observed
in patients with the most severe dysfunction (19). Operation
may improve both left ventricular function (14,20,21) and
survival (19,22), even in patients with chronic coronary
artery disease whose principal clinical manifestation is im-
pairment of left ventricular function rather than angina pec-
toris, that is, patients considered to have ischemic cardio-
myopathy.
Clinical detection of hibernating myocardium due to
impaired perfusion. These salutary results of revascular-
ization in patients with chronic coronary artery disease em-
phasize the importance of detecting hibernating myocar-
dium. This condition should be suspected in patients with
known or suspected coronary disease in whom the degree
of left ventricular failure cannot readily be accounted for
by previous myocardial infarction, regardless of the pres-
ence or severity of angina pectoris. Usually, cardiac cath-
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eterization with assessment of hemodynamics, left ventric-
ular function and coronary anatomy will be performed. If
collateral vessels or stenotic but not occluded coronary ar-
teries are found to perfuse myocardium that shows a con-
tractile defect, an effort should be made to determine whether
the tissue is necrotic or hibernating. In the latter situation
it can, like stunned myocardium (7), be "aroused" by an
inotropic stimulus, such as postextrasystolic potentiation
(23) or the infusion of a sympathomimetic amine (24). If
such improvement occurs, then it is likely that myocardial
function can be permanently improved by revascularization
carried out by surgery or coronary angioplasty. On the other
hand, if impaired left ventricular function fails to improve
with such stimulation, then it is likely that the myocardium
is irreversibly damaged and will not respond to revascular-
ization. Nesto et al. (24) reported that survival after revas-
cularization was better among patients whose ejection frac-
tion rose by more than 10% when stimulated by either
epinephrine or postextrasystolic potentiation than in those
in whom this failed to occur.
In difficult cases, a useful approach to the detection of
hibernating myocardium is to perform rest and exercise thal-
lium-20 I perfusion scans (25) and radionuclide ventricu-
lography (26). The finding of a reversible, exercise-induced
perfusion defect in an area of myocardium that exhibits
impaired wall motion suggests that the myocardial dys-
function might be related to impaired perfusion rather than
myocardial necrosis (25). Positron emission tomography has
also been used to differentiate between normal, ischemic
and infarcted myocardium and should prove useful in the
detection of hibernating myocardium. Marshall, Tillisch and
their collaborators (27,28) showed that the viability of myo-
cardium can be assessed in patients with recent infarction
by measuring regional emission of systemically adminis-
tered '8F-2-fluoro-2-deoxyglucose (FDG), which reflect ex-
ogenous glucose utilization and provides an index of myo-
cardial metabolism, and from nitrogen-13 ammonia providing
an estimate of regional perfusion. Infarcted myocardium
emits a diminished quantity of both tracers. Ischemic, but
viable, myocardium emits a diminished quantity of nitrogen-
13 ammonia because of impairment of regional perfusion,
while the emission of FDG is increased, reflecting an in-
crease in glucose utilization characteristic of viable, but
ischemic, myocardium. This disproportionate glucose uti-
lization relative to perfusion, which is indicative of isch-
emia, may correlate with the severity of left ventricular
dysfunction.
A particularly difficult problem is posed by the patient
with features of a dilated cardiomyopathy without a history
of ischemic chest pain or electrocardiographic features of
old myocardial infarction (20). In such patients it is im-
portant at least to consider the possibility that myocardial
hibernation secondary to chronic ischemia is responsible for
the impairment of left ventricular function, because revas-
cularization may result in striking clinical benefit. While
noninvasive tests, such as thallium-201 scintigraphy and
radionuclide ventriculography, may be useful in helping to
identify such patients, in the final analysis the combination
of coronary arteriography and contrast ventriculography is
necessary to determine whether ischemia plays a critical
role in the genesis of left ventricular dysfunction.
Conclusions. It is now clear that the effects of ischemia
on the myocardium are more complex than they were thought
to be even a few years ago. Rather than causing two principal
syndromes, that is, transient ischemia with equally transient
chest discomfort, electrocardiographic changes and ventric-
ular dysfunction on the one hand, and prolonged, severe
ischemia causing myocardial infarction and permanent myo-
cardial dysfunction on the other, we now recognize two
additional syndromes: prolonged postischemic cardiac dys-
function after acute ischemia (myocardial stunning) and se-
vere, persistent cardiac dysfunction secondary to chronic
ischemia with viable though poorly contractile myocardium
(cardiac hibernation). The recognition of the latter condition
is vital because the left ventricular dysfunction that char-
acterizes myocardial hibernation may be reversed by re-
vascularization, resulting in reduced disability and improved
survival.
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